ALEXANDRIA, Va., Aug. 26 -- United States Patent no. 12,396,964, issued on Aug. 26, was assigned to Shinkei Therapeutics Inc. (Princeton, N.J.).
"Amantadine hydrochloride for the treatment of traumatic brain injury" was invented by Krunal Raval (Ahmedabad, India), Suresh Borsadia (Plainsboro, N.J.), Kalpana Patel (West Windsor, N.J.) and Gurpartap Singh Sachdeva (Princeton Junction, N.J.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention is a dosing regimen for administering an aqueous composition of amantadine hydrochloride to a patient having a traumatic brain injury. The dosing regimen includes administering a first dose and a second dose of amantadine hydrochloride by intravenous injection. The...